Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell wall enzymes are a broad class of proteins essential for the synthesis, assembly, and maintenance of the protective cell wall in bacteria and fungi [2, 13]. In bacteria, these enzymes are primarily involved in the multi-stage biosynthesis of peptidoglycan, a structural polymer that provides mechanical strength and protects against osmotic pressure [8, 15]. Key bacterial members include the Mur family of enzymes, which catalyze early cytoplasmic steps, and penicillin-binding proteins (PBPs), which facilitate the final cross-linking of the cell wall in the periplasm [4, 11]. In fungi, enzymes such as beta-1,3-glucan synthase and chitin synthase are responsible for producing the core polysaccharides that maintain fungal structural integrity [3, 14]. Because human cells lack a cell wall, these enzymes are ideal therapeutic targets, allowing for high selective toxicity in the treatment of infectious diseases [7, 10]. Drugs targeting these enzymes, including beta-lactams (e.g., penicillins) and echinocandins, are cornerstone therapies for bacterial and fungal infections, respectively [5, 12]. However, the clinical utility of these drugs is frequently challenged by the development of resistance mechanisms, such as the production of inactivating enzymes or mutations in the target enzymes themselves [9, 20].
Inhibition of enzymes involved in the synthesis and cross-linking of cell wall components, such as peptidoglycan in bacteria and beta-glucans in fungi, leading to loss of structural integrity and cell lysis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell wall enzymes.